*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Temozolomide is an oral <strong>alkylating agent</strong> used in oncology. Its core synthesis involves the conversion of 5-aminoimidazole-4-carboxamide to the triazene derivative. Molecular formula: <strong>C6H6N6O2</strong>; CAS No: <strong>85622-93-1</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Production of finished dosage forms for glioblastoma multiforme.</li>
<li><strong>Contract Research:</strong> Supply of API for clinical trial formulations and stability testing.</li>
<li><strong>Distribution:</strong> Global logistics for hospital pharmacy procurement channels.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store below <strong>25°C</strong> in dry, light-resistant conditions. Handle with PPE due to potential mutagenicity. Contraindicated in pregnancy; requires rigorous hematology monitoring during therapy.</p>